Clinical Trial: Microporous Polysaccharide Hemospheres Epistaxis

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional

Official Title: Use of Microporous Polysaccharide Hemospheres (MPH) in Management of Acute Epistaxis

Brief Summary: The purpose of this study is to compare a new treatment for nosebleeds to the treatment that has been used for many years.

Detailed Summary: Nosebleeds are a common condition which affect many Americans every day.The standard treatment in this hospital for nosebleeds that do not resolve with squeezing the nose or nasal spray is to place a nasal packing (aka nasal tampon) into the nose. This is an effective treatment in most cases, but patients may find it to be uncomfortable. The investigators will be comparing the standard nasal packing with a new type of powder which may also stop nosebleeds.
Sponsor: Emory University

Current Primary Outcome: Number of subjects with resolution of bleed [ Time Frame: 15 minutes (average time to resolve bleeding) ]

Resolution of bleeding is determined by cessation of blood flow anteriorly from the nares as well as posteriorly in the pharynx. This will be determined by the otolaryngology resident or attending managing the patient during the study.


Original Primary Outcome: Same as current

Current Secondary Outcome: Time until resolution of bleeding [ Time Frame: 15 minutes (average time to resolve bleeding) ]

Number of minutes it takes to resolve bleeding comparing the Arista powder group versus the Merocel tampon group.


Original Secondary Outcome: Same as current

Information By: Emory University

Dates:
Date Received: June 5, 2015
Date Started: January 1, 2015
Date Completion:
Last Updated: January 25, 2017
Last Verified: January 2017